Rezolute (RZLT) Depreciation & Amortization (CF) (2014 - 2026)
Rezolute (RZLT) posted Depreciation & Amortization (CF) of $8000.0 for Q1 2026, up 14.29% sequentially from $7000.0 in Q4 2025, and up 14.29% YoY from $7000.0 in Q1 2025.
Rezolute (RZLT) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Rezolute has reported Depreciation & Amortization (CF) for 13 years, with the latest figure at $8000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 14.29% year-over-year to $8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31000.0 (up 3.33% YoY) and the FY2025 annual result came in at $31000.0, down 13.89% from the prior year.
- Depreciation & Amortization (CF) grew to $8000.0 in Q1 2026 per RZLT's latest filing, from $7000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $11000.0 in Q1 2023 and troughed at $3000.0 in Q1 2022.
- A 5-year average of $7411.8 and a median of $8000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) slipped 25.0% in 2022, then jumped 266.67% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $7000.0 in 2022, then jumped by 42.86% to $10000.0 in 2023, then slipped by 20.0% to $8000.0 in 2024, then retreated by 12.5% to $7000.0 in 2025, then increased by 14.29% to $8000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $8000.0, $7000.0, and $8000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2023 | 10,000.00 |